Tranexamic Acid
NDC 50268-772, Tranexamic Acid, tablet, from AvPAK.
- Product NDC
- 50268-772
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA022430
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50268-772 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRANEXAMIC ACID650 mg/1
Pharmacologic classes
Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-772-13 | 50268077213 | 30 BLISTER PACK in 1 BOX (50268-772-13) / 1 TABLET in 1 BLISTER PACK (50268-772-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e8cdb0d6-9498-2902-e053-2995a90a9de4NADAC price for package 50268077213
GET /v1/drugs/nadac/50268077213
Use it
Look up 50268-772 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-772 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-772. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.